Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients
Abstract COVID-19 pandemic exerts a health care emergency around the world. The illness severity is heterogeneous. It is mostly unknown why some individuals who are positive for SARS-CoV-2 antibodies stay asymptomatic while others show moderate to severe disease symptoms. Reliable biomarkers for ear...
Main Authors: | Alhaji H. Janneh, Mohamed Faisal Kassir, Connor J. Dwyer, Paramita Chakraborty, Jason S. Pierce, Patrick A. Flume, Hong Li, Satish N. Nadig, Shikhar Mehrotra, Besim Ogretmen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-93857-7 |
Similar Items
-
Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response
by: Silvia Vaena, et al.
Published: (2021-05-01) -
Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patients
by: Connor J. Dwyer, et al.
Published: (2021-06-01) -
A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
by: Allison N. Grossberg, et al.
Published: (2021-02-01) -
Outcomes of asymptomatic and symptomatic rheumatic heart disease
by: Zühlke, Liesl Joanna
Published: (2016) -
Asymptomatic and Symptomatic Carotid Stenosis: An Obsolete Classification?
by: Anastasios Chatzikonstantinou, et al.
Published: (2012-01-01)